Who makes Infudopa s.c.?

Infudopa s.c. is developed by Vastra Gotaland Region.

Last reviewed 2026-04-19 · How we verify

Infudopa s.c.

Vastra Gotaland Region · Phase 1 active Small molecule

At a glance

Generic name	Infudopa s.c.
Also known as	Infudopa SubC
Sponsor	Vastra Gotaland Region
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Infudopa s.c. CI brief — competitive landscape report
Infudopa s.c. updates RSS · CI watch RSS
Vastra Gotaland Region portfolio CI